Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 11:13:2631774520935239.
doi: 10.1177/2631774520935239. eCollection 2020 Jan-Dec.

Overview of bariatric and metabolic endoscopy interventions

Augustine Tawadros  1 , Michael Makar  1 , Michel Kahaleh  2 , Avik Sarkar  2
Affiliations
Review

Overview of bariatric and metabolic endoscopy interventions

Augustine Tawadros et al. Ther Adv Gastrointest Endosc. .

Abstract

The rise of endoscopic techniques allowing weight loss offers an attractive alternative to surgical interventions in Western countries where the obesity epidemic has risen dramatically. Endoscopists are well positioned to manage obesity given their broad-based medical knowledge, understanding of gastrointestinal physiology, and training in endoscopic technique. The field of bariatric and metabolic endoscopy has permitted the development of several efficacious and safe technologies. This review focuses on techniques and devices used for endoscopic management of obesity, as well as the fundamental justifications to offer those therapies to obese patients.

Keywords: bariatric; endobariatric therapy; endoscopic sleeve gastroplasty.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Michel Kahaleh has done consulting work for Boston Scientific, Interscope Med, and Abbvie. He has received research grants from Boston Scientific, Emcision, Conmed, Pinnacle, Cook, Gore, Merit, and Olympus. The other authors have no conflict of interest to report.

Figures

Figure 1.
Figure 1.
Aspiration therapy. Source: Jirapinyo and Thompson.
Figure 2.
Figure 2.
Orbera gastric balloon. Source: Jirapinyo and Thompson.
Figure 3.
Figure 3.
Reshape Duo intragastric balloon. Source: Jirapinyo and Thompson.
Figure 4.
Figure 4.
Endoscopic sleeve gastroplasty. Source: Jirapinyo and Thompson.
Figure 5.
Figure 5.
Primary obesity surgery endoluminal. Source: Jirapinyo and Thompson.
Figure 6.
Figure 6.
Endomina suturing system. Source: Huberty and colleagues.
Figure 7.
Figure 7.
Duodenal mucosal resurfacing. Source: Gong and Kim.
Figure 8.
Figure 8.
Endoluminal magnetic partial jejunal diversion. Source: Gong and Kim.
Figure 9.
Figure 9.
Duodenal-jejunal bypass liner. Source: Gong and Kim.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Hales CM, Carroll MD, Fryar CD, et al. Prevalence of obesity among adults and youth: United States, 2015-2016. NCHS Data Brief 2017; 288: 1–8. - PubMed
    1. Fock KM, Khoo J. Diet and exercise in management of obesity and overweight. J Gastroenterol Hepatol 2013; 28(Suppl. 4): 59–63. - PubMed
    1. Aronne LJ, Wadden TA, Peterson C, et al. Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults. Obesity 2013; 21: 2163–2171. - PubMed
    1. Torgerson JS, Hauptman J, Boldrin MN, et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27: 155–161. - PubMed
    1. Allison DB, Gadde KM, Garvey WT, et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity 2012; 20: 330–342. - PMC - PubMed

LinkOut - more resources